Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–15 of 15 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT05705531
- Conditions
- Cardiovascular Diseases, Cardiovascular Disorder, Classic Hodgkin Lymphoma, +1 more
- Locations
-
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Connecticut Children's Medical Center Hartford, Connecticut, United States
NCT06745076
- Conditions
- Advanced Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Lugano Classification Stage III Hodgkin Lymphoma AJCC v8, +1 more
- Locations
-
- City of Hope Irvine, California, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Washington University in St. Louis St Louis, Missouri, United States
NCT06377540
- Conditions
- Autologous Stem Cell Transplant, Classic Hodgkin Lymphoma
- Locations
-
- Masonic Cancer Center Minneapolis, Minnesota, United States
NCT07555210
- Conditions
- Adenocarcinoma, Breast Cancer (Triple Negative Breast Cancer (TNBC)), Breast Diseases, +44 more
- Locations
-
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT07275216
- Conditions
- Classic Hodgkin Lymphoma
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Not Yet Recruiting
ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
NCT07021989
- Conditions
- Classic Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +9 more
- Locations
-
- University of California Davis Davis, California, United States
- University of California San Francisco-Fresno Fresno, California, United States
- University of California Irvine Irvine, California, United States
- University of California, San Diego La Jolla, California, United States
NCT01771107
- Conditions
- AIDS-Related Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma, +23 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- UCLA Center for Clinical AIDS Research and Education Los Angeles, California, United States
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT00654732
- Conditions
- Classic Hodgkin Lymphoma, Lugano Classification Stage III Hodgkin Lymphoma AJCC v8, Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8
- Locations
-
- University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
- Rush University Medical Center Chicago, Illinois, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma
NCT06164275
- Conditions
- Classic Hodgkin Lymphoma
- Locations
-
- Stanford Cancer Center Stanford, California, United States
- Northwestern University Chicago, Illinois, United States
- Northwestern Delnor IL258 Geneva, Illinois, United States
- Cadence Health - CDH Warrenville, Illinois, United States
Active, Not Recruiting
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
NCT03907488
- Conditions
- Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma, Ann Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma, +16 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
Active, Not Recruiting
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma
NCT02166463
- Conditions
- Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma, Ann Arbor Stage IVA Hodgkin Lymphoma, +3 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
Active, Not Recruiting
Nivolumab & Brentuximab Vedotin Consolidation After Autologous SCT in Patients With High-Risk Classical Hodgkin Lymphoma
NCT03057795
- Conditions
- Classic Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +9 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Active, Not Recruiting
Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma
NCT03233347
- Conditions
- Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage IA Hodgkin Lymphoma, Ann Arbor Stage IB Hodgkin Lymphoma, +4 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
Active, Not Recruiting
Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma
NCT02758717
- Conditions
- Ann Arbor Stage IB Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma, +8 more
- Locations
-
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Mayo Clinic Rochester, Minnesota, United States
Active, Not Recruiting
Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma
NCT03712202
- Conditions
- Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Lymphocyte-Depleted Classic HL, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma, +20 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- City of Hope Medical Center Duarte, California, United States
- University of California San Diego San Diego, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States